In addition to 90,000 of its OneTouch VerioIQ (VerioIQ) blood glucose meters sold in the U.S., LifeScan, Inc. (LifeScan) a subsidiary of Johnson & Johnson (J&J), is recalling two other models sold in international markets. Over 670,000 OneTouch VerioPro Meters (VerioPro) were recalled in Europe, as well as, 4,900 OneTouch VerioPro + Meters (VerioPro +) used in hospitals and clinics outside the U.S.
Each model malfunctions in a slightly different manner. The VerioIQ automatically shuts off at blood glucose levels of 1024 mg/dL or higher. The VerioPro displays and stores an incorrect reading, which is the actual blood glucose level minus 1024 mg/dL. Finally, the VerioPro + correctly displays the warning message, but stores an incorrect reading – again, the actual blood glucose level minus 1024 mg/dL. While patients in the US have been informed that they may continue to use their current meters, provided they are aware of the defect, those outside of the country have been told to stop using OneTouch VerioPro meters immediately.
Additionally, while no reports of patient injury have been verified in the U.S., one incident has been linked to the VerioPro. But, it has not yet been determined whether there is a causal relationship between the two.
All other OneTouch blood glucose brands sold in the U.S., including OneTouch Ultra Meters, OneTouch Select Meters and OneTouch Verio Test Strips, are not affected.
The recall of the various LifeScan OneTouch blood glucose meters is the latest of close to three dozen recalls since 2009 by J&J, the world’s biggest provider of health care products.
Most of these recalls involved nonprescription medications, such as Infants’ Tylenol. But, others include faulty hip replacements and prescription drugs. The reasons for the recalls of varied, from inaccurate levels of active ingredients in medicines, the presence of glass or metal shards in liquid medicines, to nauseating packaging smells.
In response to increased FDA scrutiny, J&J is completely rebuilding one nonprescription medicine factory from the ground up and upgrading numerous other facilities.
If you or a loved one has experienced complications from use of a LifeScan OTVIQ, you may be entitled to legal remedies. The attorneys of McEldrew Law have decades of success, litigating complex personal injury matters, related to product defects and medical device malfunction. Moreover, to assist with your case, the staff of McEldrew Law includes a pharmaceutical diabetic engineer, formerly the in-house engineer for a major pharmaceutical company. Our collective experience, knowledge, and expertise has resulted in a national reputation for excellence and results. For a free and confidential consultation, contact McEldrew Law at (800) 223-3352 or jim@mceldrewlaw.com or complete the online form here.
Worldwide Recalls of LifeScan OneTouch Meter
Posted by advocateadmin in News
OneTouch® Verio®IQ
In addition to 90,000 of its OneTouch VerioIQ (VerioIQ) blood glucose meters sold in the U.S., LifeScan, Inc. (LifeScan) a subsidiary of Johnson & Johnson (J&J), is recalling two other models sold in international markets. Over 670,000 OneTouch VerioPro Meters (VerioPro) were recalled in Europe, as well as, 4,900 OneTouch VerioPro + Meters (VerioPro +) used in hospitals and clinics outside the U.S.
Each model malfunctions in a slightly different manner. The VerioIQ automatically shuts off at blood glucose levels of 1024 mg/dL or higher. The VerioPro displays and stores an incorrect reading, which is the actual blood glucose level minus 1024 mg/dL. Finally, the VerioPro + correctly displays the warning message, but stores an incorrect reading – again, the actual blood glucose level minus 1024 mg/dL. While patients in the US have been informed that they may continue to use their current meters, provided they are aware of the defect, those outside of the country have been told to stop using OneTouch VerioPro meters immediately.
Additionally, while no reports of patient injury have been verified in the U.S., one incident has been linked to the VerioPro. But, it has not yet been determined whether there is a causal relationship between the two.
All other OneTouch blood glucose brands sold in the U.S., including OneTouch Ultra Meters, OneTouch Select Meters and OneTouch Verio Test Strips, are not affected.
The recall of the various LifeScan OneTouch blood glucose meters is the latest of close to three dozen recalls since 2009 by J&J, the world’s biggest provider of health care products.
Most of these recalls involved nonprescription medications, such as Infants’ Tylenol. But, others include faulty hip replacements and prescription drugs. The reasons for the recalls of varied, from inaccurate levels of active ingredients in medicines, the presence of glass or metal shards in liquid medicines, to nauseating packaging smells.
In response to increased FDA scrutiny, J&J is completely rebuilding one nonprescription medicine factory from the ground up and upgrading numerous other facilities.
If you or a loved one has experienced complications from use of a LifeScan OTVIQ, you may be entitled to legal remedies. The attorneys of McEldrew Law have decades of success, litigating complex personal injury matters, related to product defects and medical device malfunction. Moreover, to assist with your case, the staff of McEldrew Law includes a pharmaceutical diabetic engineer, formerly the in-house engineer for a major pharmaceutical company. Our collective experience, knowledge, and expertise has resulted in a national reputation for excellence and results. For a free and confidential consultation, contact McEldrew Law at (800) 223-3352 or jim@mceldrewlaw.com or complete the online form here.